Tau pathology in cognitively normal older adults

[1]  Ninon Burgos,et al.  New advances in the Clinica software platform for clinical neuroimaging studies , 2019 .

[2]  Keith A. Johnson,et al.  Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured by Positron Emission Tomography in Clinically Normal Older Adults , 2019, JAMA neurology.

[3]  Stephen Salloway,et al.  A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer’s disease dementia , 2019, Brain : a journal of neurology.

[4]  William J. Jagust,et al.  Effect of Off-Target Binding on 18F-Flortaucipir Variability in Healthy Controls Across the Life Span , 2019, The Journal of Nuclear Medicine.

[5]  Ross D. Markello,et al.  AtlasReader: A Python package to generate coordinate tables, region labels, and informative figures from statistical MRI images , 2019, J. Open Source Softw..

[6]  Theresa M. Harrison,et al.  Longitudinal tau accumulation and atrophy in aging and alzheimer disease , 2019, Annals of neurology.

[7]  Keith A. Johnson,et al.  The impact of amyloid‐beta and tau on prospective cognitive decline in older individuals , 2018, Annals of neurology.

[8]  P. Rabins,et al.  Neuropathologic, genetic, and longitudinal cognitive profiles in primary age-related tauopathy (PART) and Alzheimer's disease , 2018, Alzheimer's & Dementia.

[9]  Brian A. Gordon,et al.  Widespread distribution of tauopathy in preclinical Alzheimer's disease , 2018, Neurobiology of Aging.

[10]  Brian A. Gordon,et al.  Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease , 2018, Neurology.

[11]  L. Ferrucci,et al.  Effects of amyloid pathology and neurodegeneration on cognitive change in cognitively normal adults , 2018, Brain : a journal of neurology.

[12]  N. Tustison,et al.  Longitudinal and cross-sectional structural magnetic resonance imaging correlates of AV-1451 uptake , 2018, Neurobiology of Aging.

[13]  Christopher G Schwarz,et al.  Longitudinal tau PET in ageing and Alzheimer’s disease , 2018, Brain : a journal of neurology.

[14]  Theresa M. Harrison,et al.  Entorhinal Tau Pathology, Episodic Memory Decline, and Neurodegeneration in Aging , 2017, The Journal of Neuroscience.

[15]  Daniel R. Schonhaut,et al.  Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer's Disease , 2017, NeuroImage: Clinical.

[16]  PET Tau and Amyloid-β Burden in Mild Alzheimer's Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid Biomarkers. , 2018, Journal of Alzheimer's disease : JAD.

[17]  Keith A. Johnson,et al.  18F-Flortaucipir Binding in Choroid Plexus: Related to Race and Hippocampus Signal. , 2018, Journal of Alzheimer's disease : JAD.

[18]  Steven Staelens,et al.  A simulation study on the impact of the blood flow-dependent component in [18F]AV45 SUVR in Alzheimer’s disease , 2017, PloS one.

[19]  Keith A. Johnson,et al.  Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global &bgr;-Amyloid Burden , 2017, JAMA neurology.

[20]  William T. Hu,et al.  Race modifies the relationship between cognition and Alzheimer’s disease cerebrospinal fluid biomarkers , 2017, Alzheimer's Research & Therapy.

[21]  W. Jagust,et al.  Considerations and code for partial volume correcting [18F]-AV-1451 tau PET data , 2017, Data in brief.

[22]  William J. Jagust,et al.  Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease , 2017, NeuroImage.

[23]  Reisa A. Sperling,et al.  The association between tau PET and retrospective cortical thinning in clinically normal elderly , 2017, NeuroImage.

[24]  James B. Rowe,et al.  PET Tau and Amyloid-β Burden in Mild Alzheimer’s Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid Biomarkers , 2017, Journal of Alzheimer's disease : JAD.

[25]  Keith A. Johnson,et al.  Functional network integrity presages cognitive decline in preclinical Alzheimer disease , 2017, Neurology.

[26]  Vanessa Sochat,et al.  Singularity: Scientific containers for mobility of compute , 2017, PloS one.

[27]  M. Mintun,et al.  Association between tau deposition and antecedent amyloid-&bgr; accumulation rates in normal and early symptomatic individuals , 2017, Brain : a journal of neurology.

[28]  K. Blennow,et al.  Ex vivo18O-labeling mass spectrometry identifies a peripheral amyloid β clearance pathway , 2017, Molecular Neurodegeneration.

[29]  A. Nordberg,et al.  Tau PET imaging: present and future directions , 2017, Molecular Neurodegeneration.

[30]  M. Mintun,et al.  Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition , 2017, Brain : a journal of neurology.

[31]  Kris Thielemans,et al.  PETPVC: a toolbox for performing partial volume correction techniques in positron emission tomography , 2016, Physics in medicine and biology.

[32]  Satrajit S. Ghosh,et al.  Sharing brain mapping statistical results with the neuroimaging data model , 2016, Scientific Data.

[33]  A. Fagan,et al.  Evaluation of Tau Imaging in Staging Alzheimer Disease and Revealing Interactions Between β-Amyloid and Tauopathy. , 2016, JAMA neurology.

[34]  Keith A. Johnson,et al.  In Vivo Tau, Amyloid, and Gray Matter Profiles in the Aging Brain , 2016, The Journal of Neuroscience.

[35]  Lilah M. Besser,et al.  Neuropathologic differences by race from the National Alzheimer's Coordinating Center , 2016, Alzheimer's & Dementia.

[36]  Yi Su,et al.  Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's disease , 2016, Science Translational Medicine.

[37]  Daniel R. Schonhaut,et al.  Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease. , 2016, Brain : a journal of neurology.

[38]  Daniel R. Schonhaut,et al.  PET Imaging of Tau Deposition in the Aging Human Brain , 2016, Neuron.

[39]  Christos Davatzikos,et al.  MUSE: MUlti-atlas region Segmentation utilizing Ensembles of registration algorithms and parameters, and locally optimal atlas selection , 2016, NeuroImage.

[40]  Yihui Xie,et al.  A General-Purpose Package for Dynamic Report Generation in R , 2016 .

[41]  Christopher J. Owen,et al.  Tau and Ab imaging, CSF measures, and cognition in Alzheimer’s disease , 2016 .

[42]  Keith A. Johnson,et al.  Validating novel tau positron emission tomography tracer [F‐18]‐AV‐1451 (T807) on postmortem brain tissue , 2015, Annals of neurology.

[43]  Yihui Xie,et al.  Dynamic Documents with R and knitr , 2015 .

[44]  Daniel S. Margulies,et al.  NeuroVault.org: a web-based repository for collecting and sharing unthresholded statistical maps of the human brain , 2014, bioRxiv.

[45]  H. Braak,et al.  PART is part of Alzheimer disease , 2015, Acta Neuropathologica.

[46]  I. Dewachter,et al.  Models of β-amyloid induced Tau-pathology: the long and “folded” road to understand the mechanism , 2014, Molecular Neurodegeneration.

[47]  Janna H. Neltner,et al.  Primary age-related tauopathy (PART): a common pathology associated with human aging , 2014, Acta Neuropathologica.

[48]  Bradley T. Hyman,et al.  The Intersection of Amyloid Beta and Tau at Synapses in Alzheimer’s Disease , 2014, Neuron.

[49]  Michael Eickenberg,et al.  Machine learning for neuroimaging with scikit-learn , 2014, Front. Neuroinform..

[50]  C. Jack,et al.  Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers , 2013, The Lancet Neurology.

[51]  I. Grundke‐Iqbal,et al.  Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration. , 2012, Journal of Alzheimer's disease : JAD.

[52]  Erik B. Erhardt,et al.  Data Visualization in the Neurosciences: Overcoming the Curse of Dimensionality , 2012, Neuron.

[53]  K. Jellinger,et al.  Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature , 2012, Journal of neuropathology and experimental neurology.

[54]  Satrajit S. Ghosh,et al.  Nipype: A Flexible, Lightweight and Extensible Neuroimaging Data Processing Framework in Python , 2011, Front. Neuroinform..

[55]  Denise C. Park,et al.  Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[56]  M. Modat,et al.  The importance of appropriate partial volume correction for PET quantification in Alzheimer’s disease , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[57]  Arno Klein,et al.  A reproducible evaluation of ANTs similarity metric performance in brain image registration , 2011, NeuroImage.

[58]  Cedric E. Ginestet.  ggplot2: Elegant Graphics for Data Analysis , 2011 .

[59]  Jörn Diedrichsen,et al.  A probabilistic MR atlas of the human cerebellum , 2009, NeuroImage.

[60]  Xenophon Papademetris,et al.  More accurate Talairach coordinates for neuroimaging using non-linear registration , 2008, NeuroImage.

[61]  Yun Zhou,et al.  Using a reference tissue model with spatial constraint to quantify [11C]Pittsburgh compound B PET for early diagnosis of Alzheimer's disease , 2007, NeuroImage.

[62]  C. Jack,et al.  Alzheimer's Disease Neuroimaging Initiative , 2008 .

[63]  David A Bennett,et al.  Sex differences in the clinical manifestations of Alzheimer disease pathology. , 2005, Archives of general psychiatry.

[64]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[65]  Michael Brady,et al.  Improved Optimization for the Robust and Accurate Linear Registration and Motion Correction of Brain Images , 2002, NeuroImage.

[66]  D. Delis,et al.  California Verbal Learning Test--Second Edition , 2016 .

[67]  Karl J. Friston,et al.  Human Brain Function , 1997 .

[68]  Karl J. Friston,et al.  Spatial transformation of images , 1997 .

[69]  J. Morris.  The Clinical Dementia Rating (CDR) , 1993, Neurology.

[70]  Isabelle Rouleau,et al.  Quantitative and qualitative analyses of clock drawings in Alzheimer's and Huntington's disease , 1992, Brain and Cognition.

[71]  R. Reitan.  Trail Making Test: Manual for Administration and Scoring , 1992 .

[72]  M. Torrens.  Co-Planar Stereotaxic Atlas of the Human Brain—3-Dimensional Proportional System: An Approach to Cerebral Imaging, J. Talairach, P. Tournoux. Georg Thieme Verlag, New York (1988), 122 pp., 130 figs. DM 268 , 1990 .

[73]  R. A. Crowther,et al.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease , 1989, Neuron.

[74]  C. Jack,et al.  Anterior temporal lobes and hippocampal formations: normative volumetric measurements from MR images in young adults. , 1989, Radiology.

[75]  D. Delis,et al.  The California verbal learning test , 2016 .

[76]  R. Katzman.,et al.  Alzheimer's disease : senile dementia and related disorders , 1978 .

[77]  J. R. Wilson,et al.  Cognitive Abilities: Use of Family Data as a Control to Assess Sex and Age Differences in Two Ethnic Groups , 1975, International journal of aging & human development.

[78]  F. Newcombe,et al.  Missile wounds of the brain: a study of psychological deficits , 1969 .

[79]  Arthur L. Benton,et al.  Differential behavioral effects in frontal lobe disease , 1968 .